Oh. Sanchezsweatman et al., COMPARATIVE IN-VIVO AND IN-VITRO PROLIFERATION OF MURINE TUMOR-CELLS IN THE BONE MICROENVIRONMENT, International journal of oncology, 8(2), 1996, pp. 371-376
To examine the effect of bone microenvironmental factors on the growth
of metastatic cells, the in vivo proliferative features of three muri
ne cell lines were determined at skeletal metastatic sites and correla
ted with their ability to grow in vitro in the presence of bone-derive
d factors. Bones, ovaries, adrenals and the brain were most affected b
y metastasis, following an intraarterial injection of B16/F1 and B16/F
10 melanoma and FS/L10 fibrosarcoma cells into C57BL/6 mice. Melanoma
cells showed a marked metastatic preference for bone, while fibrosarco
ma cells developed brain metastasis in all animals. Tumor burden in bo
nes was highest (19+/-2%) for B16/F10 cells, compared to B16/F1 (10+/-
2%) or FS/L10 (3+/-1%) cells. Autoradiographic studies demonstrated or
gan- and cell type-specific differences in tumor cell proliferation, w
ith B16/F10 cells displaying the lowest labelling indexes in bone (12/-2% for B16/F10 vs 28+/-2% and 27+/-4% for B16/F1 and FS/L10 cells, r
espectively). To test if bone-derived factors differentially affected
tumor cell growth in these three cell lines H-3-thymidine uptake by th
ese tumor cells was assessed after in vitro incubation with bone-deriv
ed conditioned medium. Under these conditions, we observed stimulation
of B16/F10 cell proliferation, but inhibition of uptake in the other
two cell lines. Thus, these results demonstrate that, in this in vivo
experimental model, growth properties of metastatic cells are organ- a
nd cell type-specific. Additionally, we show that the in vitro prolife
rative behavior of tumor cells in the presence of bone-derived factors
correlates and may predict skeletal tumor growth properties in vivo.